University of Miami Miller School of Medicine's Diabetes Research Institute, Fla.

The Diabetes Research Institute, a center of excellence at the University of Miami Miller School of Medicine, is a recognized world leader in cure-focused research. Since its inception in the early 1970s, the DRI has made significant contributions to the field of diabetes research, pioneering many of the techniques used in islet transplantation. From innovations in islet isolation and transplant procedures to advances in cell biology and immunology, the DRI is now harnessing the power of emerging technologies to develop new cell-based therapies to restore insulin production.

The most comprehensive diabetes research center of its kind, the DRI is credited with changing the international research paradigm, ensuring that promising findings in the lab can be translated to patients in the fastest, safest and most efficient way possible. Through this translational process, the DRI bridges research programs in the rapidly evolving fields of pancreatic stem cell development, tissue engineering, transplant immunology, cell transdifferentiation, molecular biology and regenerative medicine, among others, to approach the cure with a true multidisciplinary strategy.

With an unwavering commitment to cure those now living with diabetes, along with its unique spirit of collaboration and fast track approach to research, the DRI is leading the international effort to cure this disease. For the millions of families affected by diabetes who are looking to the world of science for answers, the Diabetes Research Institute is the best hope for a cure.